12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
週二盤中交易時段，12只醫療保健類股走勢
Gainers
獲勝者
- Stoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out yesterday.
- Mesoblast (NASDAQ:MESO) stock moved upwards by 64.95% to $3.63. The market value of their outstanding shares is at $368.2 million.
- OpGen (NASDAQ:OPGN) shares increased by 42.1% to $0.68. The company's market cap stands at $6.7 million.
- Alpha Teknova (NASDAQ:TKNO) shares rose 36.92% to $3.3. The market value of their outstanding shares is at $134.6 million.
- Nuvation Bio (NYSE:NUVB) shares moved upwards by 32.22% to $2.98. The company's market cap stands at $651.6 million.
- Journey Medical (NASDAQ:DERM) stock moved upwards by 28.42% to $3.75. The company's market cap stands at $72.4 million. As per the press release, Q4 earnings came out 3 days ago.
- 週二的例行中，Stoke Therapeutics（納斯達克股票代碼：STOK）股價上漲了71.8％，至11.16美元。該公司的市值爲4.985億美元。該公司昨天公佈了第四季度的收益。
- Mesoblast（納斯達克股票代碼：MESO）股價上漲64.95％，至3.63美元。他們已發行股票的市值爲3.682億美元。
- OPGen（納斯達克股票代碼：OPGN）股價上漲42.1％，至0.68美元。該公司的市值爲670萬美元。
- Alpha Teknova（納斯達克股票代碼：TKNO）股價上漲36.92％，至3.3美元。他們已發行股票的市值爲1.346億美元。
- Nuvation Bio（紐約證券交易所代碼：NUVB）股價上漲32.22％，至2.98美元。該公司的市值爲6.516億美元。
- Journey Medical（納斯達克股票代碼：DERM）股價上漲28.42％，至3.75美元。該公司的市值爲7240萬美元。根據新聞稿，第四季度業績在3天前公佈。
Losers
失敗者
- NeuBase Therapeutics (NASDAQ:NBSE) stock declined by 51.8% to $0.48 during Tuesday's regular session. The company's market cap stands at $1.7 million.
- Prenetics Global (NASDAQ:PRE) shares decreased by 18.23% to $3.68. The company's market cap stands at $44.9 million.
- Equillium (NASDAQ:EQ) stock decreased by 18.04% to $2.0. The market value of their outstanding shares is at $70.2 million. As per the news, the Q4 earnings report came out yesterday.
- SCWorx (NASDAQ:WORX) shares fell 17.11% to $2.81. The company's market cap stands at $3.4 million.
- Monte Rosa Therapeutics (NASDAQ:GLUE) stock decreased by 17.03% to $7.02. The company's market cap stands at $352.0 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 15.37% to $0.83. The company's market cap stands at $3.5 million.
- 週二的例行中，NeuBase Therapeutics（納斯達克股票代碼：NBSE）股價下跌了51.8％，至0.48美元。該公司的市值爲170萬美元。
- Prenetics Global（納斯達克股票代碼：PRE）股價下跌18.23％，至3.68美元。該公司的市值爲4,490萬美元。
- Equillium（納斯達克股票代碼：EQ）股價下跌18.04％，至2.0美元。他們已發行股票的市值爲7,020萬美元。根據新聞，第四季度收益報告於昨天發佈。
- SCWorx（納斯達克股票代碼：WORX）股價下跌17.11％，至2.81美元。該公司的市值爲340萬美元。
- 蒙特羅莎療法（納斯達克股票代碼：GLUE）股價下跌17.03％，至7.02美元。該公司的市值爲3.52億美元。
- Biodexa Pharmicals（納斯達克股票代碼：BDRX）股價下跌15.37％，至0.83美元。該公司的市值爲350萬美元。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。